Le Lézard
Classified in: Health, Science and technology
Subject: PER

Axiom Health Expands Leadership Team to Accelerate Growth


SAN DIEGO, March 28, 2024 /PRNewswire/ -- Axiom Health, a leading provider of data analytics solutions for the medical device industry, today announced the appointments of Russell "Rusty" Lewis as Chief Executive Officer (CEO) and Jim Best as Chief Commercial Officer (CCO). These appointments strengthen Axiom Health's leadership capabilities as the company seeks to expand its market presence and deliver enhanced value to its clients.

Mr. Lewis brings extensive healthcare leadership experience to the CEO role, having previously served as McKesson CTO, Amerisource Bergen President of Pharmacy Automation & Technology, and CTO & CIO at Vizient. His expertise in healthcare technology and his track record of driving innovation will be instrumental in guiding Axiom Health's growth trajectory.

Mr. Best joins Axiom Health as CCO with over two decades of experience in the healthcare industry, including sales and marketing leadership roles at Stryker, Integra Lifesciences, TriMed and Komodo Health. His proven ability to understand and address the challenges of medical device sales and marketing teams will bolster Axiom Health's client success initiatives.

"We are excited to welcome Rusty and Jim to the Axiom Health team," said Jim Hinrichs, Chairman of the Board. "Rusty's leadership and strategic vision will be invaluable as we enter this next phase of growth. Jim Best's deep medical device sales and marketing experience and customer focus aligns perfectly with our commitment to delivering exceptional value in the medical device market."

About Axiom Health Axiom Health empowers sales and marketing teams in the medical device industry with the data-driven insights they need to make informed decisions and achieve better outcomes. The company's analytics platform offers an unparalleled depth of data, helping organizations optimize strategies and drive growth.

For further information, please contact: Media Relations Department at Axiom Health: [email protected] Website: www.axiomhealth.com

SOURCE Axiom Health


These press releases may also interest you

at 00:45
At Last, a Worldwide Groundbreaking Solution to Address the Unhoused Crisis
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
Flash News: OKX Wallet Integrates with Side Protocol
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
Flash News: OKX Wallet Integrates with Bitrubo
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
Cognitive Security Market Projected to Reach $134.26 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

More news about Science and technology...


News published on and distributed by: